Preventing and treating lymphatic minute metastasis with 32P-chromic phosphate during an operation

Cancer Biotherapy and Radiopharmaceuticals

Volumn 22, Issue 1, 2007, Pages 24-32

  Daozhen, Chen ^a,b   Lu, Liu ^a,d   Guansheng, Tong ^c   Zhiyong, Liu ^a   Xudong, Li ^a   Ying, Huang ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b Medical University of Nanjin   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Cardiac carcinoma; Colloids; Esophageal carcinoma; Lymphatic metastasis; Operative treatment; Phosphorus radioisotopes; Radiotherapy

Indexed keywords

ALPHA INTERFERON; CHROMIUM PHOSPHATE P 32; CISPLATIN; FLUOROURACIL;

ABDOMINAL AORTA; ADIPOSE TISSUE; ADULT; AGED; AORTA ARCH; ARTICLE; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; IRRADIATION; KAPLAN MEIER METHOD; LOG RANK TEST; LUNG HILUS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MEDIASTINUM METASTASIS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RETROPERITONEUM; STOMACH CANCER; SURGICAL MORTALITY; SURVIVAL TIME;

EID: 34247868111     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Roth JA, Putnam JB, Rich T, et al. Esophageal cancer. In: Devita VT, Hellman, Jr, S, Rosenberg SA, eds. Cancer Principles and Practice of Onclolgy. 5th ed. Philadelphia: Lippincott Raven, 2001:1013.
2. Qu ZX, Yang BH, Hang SQ, et al. Results of surgical treatment of 220 patients with lung cancer. Chin J Lung Cancer 2000;3:461.
3. Jin RX, Zhang SZ, Zheng BY, et al. Prognosis of axillary lymph nodes occult metastasis of breast cancer. Tumor 1999;19:104.
4. Bosset JF, Ginoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161.
5. Zhang AP, Luo N. Combined treatment in 239 patients with stage III esophageal cancer. Chin Oncol 2003;13:172.
6. Xiao ZF, Yang ZY, Liang J, et al. Clinical value of prophylactic radiotherapy after curative resection of esophageal carcinoma. Chin J Oncol 2002;24:608.
7. Arimoto T, Takamura A, Tomita M, et al. Intraoperative radiotherapy for esophageal carcinoma-significance of IORT dose for the incidence of fatal tracheal complication. Int J Radiat Oncol Biol Phys 1993;27:1063.
8. Yan FL, Zhou XM, Chen QX, et al. Intraoperative radiotherapy for 30 esophageal carcinoma patients. Chin J Oncol 2003;25:178.
9. Liu L, Teng GJ, Jiang Z, et al. Preliminary clinical application of phosphorus-32 glass microspheres in the interventional treating of hepatocellular carcinoma. He Jishu 2000;23:316.
10. DeNittis AS, Stambaugh MD, Lang P, et al. Complete remission of nonesectable pancreatic cancer after infusional colloidal phosphorus-32 brachytherapy, external beam radiation therapy, and 5-fluorouracil: A preliminary report. Am J Clin Oncol 1999;22(4):355.
11. Firusian N, Dempke W. An early phase II study of intratumoral P-32 chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases. Cancer 1999;85:980.
12. 32P interstitial radiotherapy with VM26 intra-artarial infusion chemotherapy for the treatment of brain tumor. Pract J Cancer 2002;17:302.
13. 32P-colloid. Br J Cancer 1999;80(12):1955.
14. Lu L, Zi-Zheng W, Hong G, et al. Study on the effect of a localized injection of P-32 chromic phosphate colloids on pancreatic carcinoma (Pc-3) and its radioactivity in lymph node. Chin J Nucl Med 2003;23:334.
15. Ilson DH, Sirott M, Saltz L, et al. A phase II trial of interferon alfa-2a 5-fluorouracil and cisplatin in patients with advanced esophageal carcinoma. Cancer. 1995;74:2197.
16. Lu L, Gao-jun T, Dong-Sheng Z, et al. Study on the toxicology of intrahepatic arterial administration of interventional phosphorus-32 glass microspheres to domestic pigs. CMJ 1999;112(7):632.
17. Lu L, Zhao J, Gao-jun T, et al. Clinical and experimental study on regional administration of phosphorus-32 glass microspheres in treating hepatic carcinoma. World J Gastroenterol 1999;5(6):492.
18. 32P chromic phosphate colloid on grafted pancreatic carcinoma Pc-3 in nude mice, Chin J Nucl Med 2003;23(5):294.
19. 32P-chromium phosphates in vitro. Chin. J Radiol Med Protect 2004;24(3):233.
20. 32P-chromic phosphate interventional treatment of implanted pancreatic carcinoma and its anticancer mechanism. WJG 2005;11(14):2101.
21. 32P-colloid interstitial irradiation on the treatment of occult lymphatic metastasis during lung cancer resection. Chin J Nucl Med 2005;25(1):33.
22. Li LJ, Feng GS, Liu L, et al. Radiochemotherapy with interstitial implantation of 125I seeds and 5-FU slow-release seeds for advanced pancreatic cancer. J Southeast Univ (Med Sci Ed) 2004;23(4):246.
23. 32P colloids or microspheres. Chin J Radiol Med Protect 2006;26(1):43.
24. Zhou FY, Han XC. Surgical treatment for esophageal and cardiac carcinoma in 13,248 cases. Chin Oncol 2003;12:256.
25. He XH, Liu SJ, Xing GQ. Statistical analysis of the lifespan of 244 esophageal carcinoma patients. J Pract Oncol 2002;16:18.
26. Order S, Siegel J, Lustig R, et al. A new method for delivering radioactive cytotoxic agents in solid cancers. Int J Radiat Oncol Biol Phys 1994;30(3):715.
27. 32P) chromic phosphate for the treatment of solid tumors. Acta Physiol Pharmacol Therapeut Latinoam 1996;46(2):103.